Article
Long-term outcome of "prophylactic therapy" for familial medullary thyroid cancer.
Surgery - 1 Nov 2009
Schellhaas Elisabeth, König Charlotte, Frank-Raue Karin, Buhr Heinz-J, Hotz Hubert G
Abstract excerpt
BACKGROUND: About one quarter of all medullary thyroid cancers (MTC) are determined genetically due to a mutation in the RET proto-oncogene. The most common site of mutation is in codon 634. Therapeutic approaches toward patients at risk for the development of MTC identified by family screening programs range from total thyroidectomy to total thyroidectomy with lymphadenectomy of all 4 compartments. METHODS: We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
